Cart
sales@molnova.com
SBE-β-CD
CAS No. 182410-00-0
SBE-β-CD ( Sulfobutylether-β-Cyclodextrin )
Catalog No. M22582 CAS No. 182410-00-0
SBE-β-CD is a sulfobutylether β-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | 59 | In Stock |
|
Biological Information
-
Product NameSBE-β-CD
-
NoteResearch use only, not for human use.
-
Brief DescriptionSBE-β-CD is a sulfobutylether β-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
-
DescriptionSBE-β-CD is a sulfobutylether β-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
-
SynonymsSulfobutylether-β-Cyclodextrin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number182410-00-0
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityDMSO:5.625 mg/mL(Need ultrasonic and warming); H2O:250 mg/mL:Need ultrasonic
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fukuda M, et al.Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.Int J Pharm. 2008 Feb 28;350(1-2):188-196
molnova catalog
related products
-
Fmoc-Ser(Ac3-b-D-Glc...
O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranosyl)-N-α-(fluoren-9-yl-methoxycarbonyl)-L-serine is an FMOC-protected glycopyranosyl-derivatized serine amino acid.
-
N-(4-Fluorophenyl)-4...
N-(4-Fluorophenyl)-4-phenyl-2-thiazolami is a potent, brain-penetrant and orally active GP130 receptor agonist.
-
ReACp53
ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, resues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC).
